No Data
Optimistic Investors Push Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) Shares Up 26% But Growth Is Lacking
GTJA: Continuous iteration of anti-tumor therapies, domestic new drugs welcome breakthroughs.
GTJA focuses on products with significant differentiation advantages and leading companies in innovative segments.
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
Zhejiang Wecome Pharmaceutical (300878.SZ) products were selected for the national Chinese Patent Medicine procurement alliance's concentrated bulk procurement (first batch expansion continuation).
Zhejiang Wecome Pharmaceutical (300878.SZ) announced that recently, the company participated in the national Chinese Patent Medicine procurement alliance's centralized volume purchasing...
Weikang Pharmaceutical: 2024 Annual Results Forecast
Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely
Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected
